Home | Welcome to Contract Pharma   
Last Updated Tuesday, January 27 2015

Print RSS Feed

Topics - Drug Discovery


Refine by Date:
From: To:
Published January 22, 2015
Will research and develop approaches to CAR T cell therapy in cancer Read More »
Published January 20, 2015
Aims to improve asset development and delivery timelines Read More »
Published January 19, 2015
To apply discovery and technology platforms to develop inhibitors for addictive disorders Read More »
Published January 14, 2015
Gains exclusive rights to oncology target Read More »
Published January 12, 2015
Will include additional oncology targets Read More »
Published January 9, 2015
Aims to identify new treatment approaches for diseases with significant unmet need Read More »
Published January 9, 2015
Includes cross-license for two programs targeting thrombosis and cardiovascular disease Read More »
Published January 9, 2015
X-Chem will apply its discovery engine to identify novel compounds Read More »
Published January 5, 2015
To develop antisense drugs to treat gastrointestinal autoimmune disorders Read More »
Published December 17, 2014
Includes a series of small molecule compounds against a cardiovascular drug target Read More »
Published December 15, 2014
Broadens access to key biotech hubs Read More »
Published December 11, 2014
X-Chem to identify drug candidates against Alexion targets Read More »
Published December 8, 2014
Will collaborate with Spark to progress SPK-FIX clinical program in hemophilia B Read More »
Published December 4, 2014
Reaffirms commitment to NJ Read More »
Published December 3, 2014
To encompass pipeline-building, outsourcing alliance, and open innovation initiatives Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On